Dipexium Pharmaceuticals

About:

Dipexium Pharmaceuticals offers small peptide antibiotics to treat certain mild and moderate skin infections in superficial wounds.

Website: http://dipexiumpharmaceuticals.com

Description:

Dipexium Pharmaceuticals operates as a biopharmaceutical company that develops and commercializes, pexiganan, a small peptide anti-infective agent. It provides Locilex, a small peptide topical antibiotic for the treatment of mild and moderate skin infections in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds, and nasal colonization of methicillin-resistant staphylococcus aureus.

Total Funding Amount:

$6.93M

Headquarters Location:

White Plains, New York, United States

Founded Date:

2010-01-01

Founders:

David Luci, Robert J. DeLuccia

Number of Employees:

11-50

Last Funding Date:

2013-07-22

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai